TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
TCL Archive DeVita Frustrated By Gap Between Bypass, “Real” Budgets, Seeks Better System To Develop Priorites April 24, 1981
TCL Archive New Core Gant Guideline Proposals Drawn Up; Opposition Developing Among Center Directors April 4, 1980
